Amgen, Inc. (NASDAQ:AMGN)

CAPS Rating: 4 out of 5

A biotechnology company which discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology.

Recs

0
Player Avatar GMoneyCaps (70.10) Submitted: 12/13/2011 7:37:39 PM : Outperform Start Price: $56.55 AMGN Score: +13.93

12/13

Featured Broker Partners


Advertisement